UBS Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Sell |
129,468
-12,468
| -9% | -$14.5K | ﹤0.01% | 5662 |
|
|
2025
Q1 | $226K | Sell |
141,936
-41,742
| -23% | -$66.4K | ﹤0.01% | 5231 |
|
|
2024
Q4 | $557K | Buy |
183,678
+154,150
| +522% | +$467K | ﹤0.01% | 4621 |
|
|
2024
Q3 | $109K | Sell |
29,528
-77,572
| -72% | -$285K | ﹤0.01% | 5110 |
|
|
2024
Q2 | $438K | Sell |
107,100
-160,765
| -60% | -$658K | ﹤0.01% | 4013 |
|
|
2024
Q1 | $4.22M | Buy |
267,865
+267,755
| +243,414% | +$4.22M | ﹤0.01% | 2345 |
|
|
2023
Q4 | $1.67K | Sell |
110
-66,723
| -100% | -$1.01M | ﹤0.01% | 7034 |
|
|
2023
Q3 | $1.34M | Sell |
66,833
-22,920
| -26% | -$460K | ﹤0.01% | 2873 |
|
|
2023
Q2 | $2.53M | Buy |
89,753
+6,344
| +8% | +$179K | ﹤0.01% | 2500 |
|
|
2023
Q1 | $1.43M | Sell |
83,409
-71,483
| -46% | -$1.23M | ﹤0.01% | 2879 |
|
|
2022
Q4 | $3.12M | Buy |
154,892
+129,897
| +520% | +$2.62M | ﹤0.01% | 2195 |
|
|
2022
Q3 | $542K | Sell |
24,995
-4,848
| -16% | -$105K | ﹤0.01% | 3302 |
|
|
2022
Q2 | $839K | Sell |
29,843
-44,412
| -60% | -$1.25M | ﹤0.01% | 3002 |
|
|
2022
Q1 | $3.43M | Buy |
74,255
+38,749
| +109% | +$1.79M | ﹤0.01% | 2246 |
|
|
2021
Q4 | $2.98M | Buy |
35,506
+35,241
| +13,298% | +$2.96M | ﹤0.01% | 2545 |
|
|
2021
Q3 | $18K | Buy |
265
+10
| +4% | +$679 | ﹤0.01% | 6159 |
|
|
2021
Q2 | $14K | Buy |
+255
| New | +$14K | ﹤0.01% | 6623 |
|
|
2021
Q1 | – | Sell |
-182
| Closed | -$9K | – | 8284 |
|
|
2020
Q4 | $9K | Buy |
+182
| New | +$9K | ﹤0.01% | 6552 |
|
|
2020
Q3 | – | Sell |
-257
| Closed | -$12K | – | 7429 |
|
|
2020
Q2 | $12K | Buy |
+257
| New | +$12K | ﹤0.01% | 6050 |
|